Stock Analiz

Crescent Biopharma, Inc. (CBIO) stock forecast and price target

Price $14.15 · data as of November 13, 2026

12-month price target

Average target$32.33
Upside / downside+128.5%
Analysts6
ConsensusStrong buy
Low $28.00Average $32.33High $40.00

Gold marker: average target · white marker: today’s price ($14.15)

Analyst ratings

Strong buy 1Buy 7Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.76+78.4%$3M
Next fiscal year
ends December 31, 2027
$-3.07−11.1%$4M
Next quarter
ends December 31, 2026
$-0.74+85.0%$833330
Quarter after
ends March 31, 2027
$-0.65+7.1%$0

Consensus of the analysts covering Crescent Biopharma, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Frequently asked questions

What is the Crescent Biopharma stock price target?

The average 12-month target from 6 analysts is $32.33, 128.5% above the current price of $14.15 Targets range from $28.00 to $40.00.

Is Crescent Biopharma a buy according to analysts?

The consensus rating is “Strong buy” (1 strong buy, 7 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Crescent Biopharma expected to earn?

Analysts expect EPS of $-2.76 for the fiscal year ending December 31, 2026 and $-3.07 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.